Signal active
Bio
Brook Byers is the Board Director of Foundation Medicine Inc. He has been a venture capital investor since 1972. He has been closely involved with more than fifty new technology based ventures, over half of which have already become public companies.
He formed the first Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 Life Sciences companies which have already developed hundreds of products to treat major underserved medical needs for millions of patients.
Brook was the founding President and then Chairman, of four biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion.
He is currently on the Board of Directors of nine companies, most recently joining CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, OptiMedica, Pacific Biosciences, Inc., Tethys, XDx, Inc
He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals, Pharmacopeia, Hybritech (Chairman), Genprobe and others. These companies have pioneered the medical use of molecular biology, monoclonal antibodies, molecular diagnostics and genomics.
Brook was President and a Director of the Western Association of Venture Capitalists. He is a currently a Board member of the University of California at San Francisco Medical Foundation, the New Schools Foundation, Stanford Bio-X Advisory Council and the Stanford Eye Council.
He was Co - Chair of the five year, $1.4 billion, UCSF Capital Campaign. In 2007, he was awarded the UCSF Medal as their honorary degree equivalent.
He was formerly a Director of the Entrepreneurs Foundation, the California Healthcare Institute, the Asian Art Museum in San Francisco, the Stanford Graduate School of Business Advisory Council, That Many May See (UCSF) Vision Research Foundation (Chairman) and the Georgia Tech Advisory Board.
Raised in Atlanta, Georgia, Brook graduated in Electrical Engineering from Georgia Tech. He received an MBA from Stanford.
Location
San Francisco, California, United States, North America
Social
Primary Organization
1972
1413
403
337
251-500
Financial Services, Venture Capital, Finance, Incubators
Jobs history
4
Board Member
Invalid date - Current
Ligand Pharmaceuticals
Founder
Invalid date - Current
Enjoy
Board Member
Invalid date - Current
Verana Health
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Brook Byers is the Co-Founder at Kleiner Perkins, based in United States, North America. With a background in Financial Services, Brook Byers has a rich history of leadership and innovation. Brook Byers studied MBA unknown @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
10
0
Personal investment
10
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jan 14, 2022 | Verana Health | Series E - Verana Health | 150.0M |
Jan 25, 2022 | Leyden Labs | Series B - Leyden Labs | 140.0M |
Feb 03, 2022 | HealthRhythms | Seed Round - HealthRhythms | 11.0M |
Jun 29, 2022 | Regard | Series A - Regard | 15.3M |
Partner investment
5
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Apr 15, 2004 | CareDx | Series C - CareDx | Kleiner Perkins | 14.8M |
Apr 26, 2006 | OptiMedica | Series B - OptiMedica | Kleiner Perkins | 0 |
Jul 14, 2008 | PacBio | Series E - PacBio | Kleiner Perkins | 100.0M |
Oct 23, 2008 | CardioDx | Series C - CardioDx | Kleiner Perkins | 20.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.